COVID-19: information for patients
An update for patients on the Covid-19 vaccine
Now that six months have passed since the vaccination rollout, Prof. Dr. Ansgar Lohse can provide an update on the state of knowledge on the COVID-19 vaccinations. Thankfully, there is good news to share.
Covid-19 vaccine: information for patients
Ansgar Lohse, ERN RARE-LIVER Coordinator and specialist in both Hepatology and in infectious diseases, provides a video message on the topic of vaccines against COVID-19, addressing the questions of patients with rare liver diseases, in particular for patients with immune mediated liver diseases and liver transplant patients.
Communication toolkit for patient organisations
We are delighted to provide information to patient organisations on how they can suppport patients during this challenging time. We hope it will help especially the very small rare disease patient organisations, to communicate effectively about COVID-19 and associated issues for liver patients.
Ansgar Lohse, Coordinator and specialist in both Hepatology and in infectious diseases, produced a video message. It directly addresses the worries and fears regarding rare liver patients and COVID-19, and it sheds light on and contextualises registry data. Many thanks to patient organisations and collaborating centres for their input.
Letter to patients in several languages
In the early stages of the COVID-19 pandemic in Europe, ERN RARE-LIVER issued a statement to rare liver patients and in case of children, their parents. Available in several languages.